1101

Economic Evaluation of Incontinence-Associated Dermatitis Prevention: Total Costs

Donna Z. Bliss, PhD, RN, FAAN, University of Minnesota School of Nursing, Professor, 5-160 Weaver-Densford Hall, 308 Harvard Street, Minneapolis, MN 55455, Cindy Zehrer, RN, MS, 3M Medical Division, Senior Clinical Research Associate, 3M Center Bldg 270-4N-01, St. Paul, MN 55144, Kay Savik, MS, University of Minnesota School of Nursing, Biostatistician, 5-160 Weaver-Densford Hall, 308 Harvard Street, Minneapolis, MN 55455, Li Ding, MS, 3M Medical Division, Statistician, 3M Center Bldg 270-4N-01, St. Paul, MN 55144, Graham Smith, BS, 3M Medical Division, Clinical Research Statistician, 3M Center Bldg 270-4N-01, St. Paul, MN 55144, and Edwin C. Hedblom, PharmD, 3M, Clinical Research Manager, 3M Center Bldg 270-4N-01, St. Paul, ME 55144.

Purpose: Prevention of incontinence dermatitis (ID) is a major focus of care for nursing home (NH) residents. Rising health care costs, an aging population and staff shortages mandate cost effective care. This study compared the total cost and efficacy of four regimens that used different products for preventing ID in NH residents.

Methods: Residents (n=1,918) in 16 U.S. NHs, randomly selected, were screened for eligibility; 981 residents qualified and were enrolled. All were incontinent and started free of perineal skin damage. Residents' age and sex did not differ among regimens. In regimen A, a barrier film was applied 3 times weekly and in regimens B, C, and D, one of three ointment barriers of different compositions were applied after each incontinence episode. Total cost of ID prevention was determined using prospective time and motion measures of staff time and number, amount of products used, and number of supplies. Staff assessed resident skin damage for 6 weeks to determine efficacy of the regimens.

Results: The median number of incontinent episodes/day differed among regimens (A=6.3, B=6.3, C=7.0, D=6.7; p=.005). Different numbers of staff provided ID prevention care (range = 1 to 4; p<.001). Due to these differences, the analysis was standardized using total costs per episode of incontinence provided by 1-2 caregivers. The median total cost of regimen A($0.89) was significantly less than B($1.74), C($1.31), and D($1.28) p<.001. Incidence of ID did not differ among regimens (A=3.5%, B=2.1%, C=4.1%, D=4.0%, p=.55). Nearly half (48%) of those developing ID were incontinent of both urine and stool.

Conclusions: A regimen for preventing ID that uses a polymer skin barrier film three times weekly resulted in a lower total cost per episode of incontinence and was as effective as regimens in which a skin barrier ointment was applied after each episode of incontinence.


See more of Oral Paper Presentations
See more of Oral Paper Presentations

See more of The WOCN Society 39th Annual Conference (June 9 -- 13, 2007)